Skip to Main Content

Paper Details

The potential of polygenic scores to improve cost and efficiency of clinical trials.
Nat Commun
14
2022
Author NameAffiliation
Anthony A PhilippakisBroad Institute of MIT and Harvard
Anthony A PhilippakisBroad Institute of MIT and Harvard
Anthony A PhilippakisBroad Institute of MIT and Harvard
Anthony A PhilippakisBroad Institute of MIT and Harvard
Amit KheraDivision of Cardiology and Center for Genomic Medicine, Massachusetts General Hospital
Amit KheraBroad Institute of Harvard and MIT
Amit KheraHarvard Medical School
Amit Khera
  • 1 - 8

Datasets

Release 1.2